Probi AB
STO:PROB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Probi AB
Total Current Liabilities
Probi AB
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Probi AB
STO:PROB
|
Total Current Liabilities
kr89.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Biogaia AB
STO:BIOG B
|
Total Current Liabilities
kr199.1m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Total Current Liabilities
kr164.3m
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Total Current Liabilities
kr615m
|
CAGR 3-Years
0%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Total Current Liabilities
kr16.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
28%
|
|
|
BioArctic AB
STO:BIOA B
|
Total Current Liabilities
kr520.8m
|
CAGR 3-Years
94%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Probi AB
Glance View
Probi AB engages in the development and sale of probiotics. The company is headquartered in Lund, Skane and currently employs 175 full-time employees. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The firm's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others. The firm is a parent of Probi Food AB and Probi Feed AB.
See Also
What is Probi AB's Total Current Liabilities?
Total Current Liabilities
89.6m
SEK
Based on the financial report for Sep 30, 2024, Probi AB's Total Current Liabilities amounts to 89.6m SEK.
What is Probi AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
13%
Over the last year, the Total Current Liabilities growth was 4%. The average annual Total Current Liabilities growth rates for Probi AB have been 8% over the past three years , 2% over the past five years , and 13% over the past ten years .
